ACROBiosystems


ACROBiosystems develops recombinant antigens for emergency SARS-CoV-2 variants. They also produce a series of GMP-grade cytokines under the GMP-quality management system. Their products include fc receptor proteins, immune checkpoint proteins, llama IgG fc fusion proteins, biomarkers, CD antigens, and more.

Industries

biotechnology

Nr. of Employees

large (251-1000)

ACROBiosystems

Newark, Delaware, United States, North America


Patents

Anti-BCMA antibodies

US-12116415-B2

View Details

Products

Recombinant Proteins

Proteins produced through recombinant DNA technology used in biomedical research and drug development.

Antibodies

Various antibodies including immunohistochemistry antibodies, anti-payload antibodies, anti-idiotypic antibodies, and universal antibodies for research and therapeutic development.

Cell Culture Reagents

Reagents including GMP-grade cytokines, growth factors, serum-free media, and activation beads for cell culture and cell therapy manufacturing.

Gene Editing Products

Gene editing enzymes and related tools including GMP-grade Cas nucleases and nucleic acid removal nucleases for gene and cell therapy research.

ELISA Kits and Assay Reagents

Immunoassay kits and reagents for detecting cytokines, biomarkers, antibodies, and residual contaminants in biological samples.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.